Business News

Innovative Start-Ups at CPHI Barcelona

October 15, 2023

The Start-Up Market at CPHI Barcelona will bring together 27 start-ups, innovators, and small enterprises from across the pharma landscape.

Cellares Expands Agreement with Bristol Myers Squibb for Second CAR-T Program

October 13, 2023

Under an expanded agreement, Cellares will provide proof-of-concept manufacturing for a second CAR-T cell therapy from Bristol Myers Squibb.

Bristol Myers Squibb Acquires Mirati Therapeutics for up to $5.8 Billion

October 12, 2023

Mirati’s focus on breakthrough cancer treatments will bolster Bristol Myers Squibb’s oncology portfolio.

Salipro Biotech and Icosagen to Collaborate on Antibody Discovery

October 12, 2023

Salipro Biotech and Icosagen have entered into a multi-target collaboration to discover and characterize monoclonal antibodies.

BIOVECTRA in Tech Transfer Agreement with Acuitas Therapeutics for LNP Delivery System

October 11, 2023

Under this agreement, Acuitas Therapeutics’ LNP technology platform will be transferred to BIOVECTRA for use in manufacturing mRNA-based therapies.

Roche to Develop Two Novel RNA-targeted Programs from Ionis for CNS Diseases

October 11, 2023

Roche will gain exclusive worldwide rights to develop, manufacture, and commercialize Ionis’ investigational RNA-based therapeutic candidates for Alzheimer's and Huntington's disease.

Advent International, Warburg Pincus Complete $4.25 Billion Acquisition of Baxter’s BioPharma Solutions Business

October 02, 2023

The newly established business under Advent International and Warburg Pincus will be named Simtra BioPharma Solutions.

Sartorius and SPARTA Biodiscovery Partner on Novel Nanoparticle Analysis Platform

September 29, 2023

Under the partnership, Sartorius will leverage SPARTA Biodiscovery’s technology to accelerate development of nanoparticles used for drug delivery.

MilliporeSigma Opens Two New GMP Manufacturing Sites in Germany for mRNA Production

September 28, 2023

With the two new GMP-grade mRNA manufacturing sites in Germany, MilliporeSigma can now offer fully integrated mRNA services.

Genentech Partners with Orionis Biosciences to Discover and Develop Molecular Glue Class Medicines

September 20, 2023

Under the collaboration, Orionis will receive $47 million upfront to leverage its Allo-Glue platform to discover small-molecule monovalent glues.